R

Redesign Health

Builds and scales new healthcare companies

New Ventures Associate

Full-Time
No salary listed
Junior, Mid
Bachelor's
Los Angeles, CA, USA+1 moreMore locations: New York, NY, USA
HybridThree to four days onsite per week required in the Los Angeles Cedars-Sinai office.
Finance & BankingVenture Capital

About the job

Requirements
  • At least 1 year and up to 3 years of experience in venture capital, early-stage investing, startups, banking, private equity, consulting, strategy, research, or a related field.
  • Fluency in business model analysis, primary and secondary research, investment thesis development, and financial modeling.
  • A bachelor's degree with demonstrated academic excellence.
  • Ability to develop original investment theses across care delivery, health technology, and digital health.
  • Ability to earn credibility with clinicians, operators, and entrepreneurs.
  • Ability to work quickly and comfortably with ambiguity and provide succinct answers to complex problems.
  • Ability to translate analyses into concise insights for senior leaders, investment committees, and management teams.
  • Ability to work independently, own execution, and proactively improve workflows.
  • Ability to leverage artificial intelligence and emerging technology tools to improve productivity and impact.
Responsibilities
  • Evaluate and research commercial opportunities in healthcare.
  • Identify commercially viable opportunities that address specific challenges within Cedars-Sinai and systemic challenges faced by health systems across the country, while aligning with organizational goals.
  • Apply Redesign Health scoring frameworks and venture-building methodologies to evaluate, prioritize, and refine innovation opportunities.
  • Direct opportunities that do not meet the threshold for a new or scalable venture to appropriate teams or channels within Cedars-Sinai.
  • Promote the innovation program across the organization and foster a culture of creativity and innovation among staff.
  • Engage with stakeholders across Cedars-Sinai departments and institutes to understand organizational needs and foster collaboration.
  • Identify and evaluate opportunity zones to determine whether viable investment theses exist for company creation.
  • Develop an end-to-end pathway from opportunity submission and research through evaluation and execution, using internal submissions, research areas, and founder referrals.
  • Build and maintain a network of external founders aligned with Cedars-Sinai strategic priorities.
  • Evaluate external founders for partnership and company creation opportunities that advance Cedars-Sinai's mission and innovation objectives.
  • Provide strategic guidance to founders before and after operating company formation.
  • Connect founders with Cedars-Sinai stakeholders, resources, clinicians, and ecosystem partners.
  • Lead the development and launch of new venture-backed companies based on validated opportunities.
  • Launch at least one new company annually in partnership with a founder and translate identified opportunities into scalable healthcare businesses.
Desired Qualifications
  • Healthcare domain expertise with the ability to develop original investment theses across care delivery, health technology, and digital health.
  • Exposure to healthcare and digital health in investing, banking, venture capital, private equity, consulting, strategy, or related research.

About the company

Redesign Health builds and scales new healthcare companies from the ground up. It ideates based on identified health needs, recruits top founders, and creates startups that focus on patient solutions and provider support. The process involves in-house research, due diligence, and leveraging a network of over 200 healthcare incumbents to identify opportunities, then launching and rapidly growing these ventures until they become profitable. Revenue comes from the services provided by the portfolio companies, with potential exits through acquisitions or public offerings. Unlike firms that only invest in existing businesses, Redesign Health creates new companies designed to address significant health challenges. Their goal is to improve human health by delivering scalable, market-ready healthcare solutions and sustaining growth for the ventures they build.

Company Size

201-500

Company Stage

Late Stage VC

Total Funding

$492.4M

Headquarters

New York City, New York

Founded

2018

Get referred to Redesign Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • June 2026 India expansion opens a large, digital-first healthcare market for new ventures.
  • OmicsBank raised $2.25 million from Redesign on August 25, 2026, signaling active deployment.
  • The 12-person India team and Sky Impact partnership accelerate sourcing, diligence, and partnerships.

What critics are saying

  • Idea-stage healthcare AI bets need long regulatory and reimbursement cycles before meaningful revenue.
  • Backing only five to six India startups yearly concentrates losses if launches stall.
  • If portfolio exits keep lagging, Redesign becomes a talent-heavy studio without compounding returns.

What makes Redesign Health unique

  • Redesign Health builds companies, not just backs them, from ideation through exit.
  • Its June 2026 India fund targets healthcare AI founders at pre-seed and ideation.
  • The platform’s operator network spans U.S., Middle East, and India healthcare incumbents.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Full medical, dental, and vision coverage with no monthly contribution for you and your dependents (for all of our plans!)
  • Quarterly in-home house cleaning
  • $50 a month wellness stipend
  • 401K match
  • Student loan repayment contribution
  • Tax preparation services
  • Unlimited PTO
  • An annual 2-week company-wide winter break
  • 2 months sabbatical after 4 years
  • Reimbursements to Spotify & Headspace
  • 16 week full paid parental leave
  • Maven Clinic access with $10k lifetime contributions to fertility & adoption services

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

0%
MobiHealthNews
Oct 14th, 2026
Exclusive: Treso raises $3.75M for financial software for healthcare

The Redesign Health-backed company plans to launch in December and will provide independent physician practices with tools for accounting and cash flow management.

RamaOnHealthcare
Oct 14th, 2026
Exclusive: Treso raises $3.75M for financial software for healthcare.

Exclusive: Treso raises $3.75M for financial software for healthcare. MobiHealth News October 14, 2026 Jessica Hagen The Redesign Health-backed company plans to launch in December and will provide independent physician practices with tools for accounting and cash flow management. Treso, a company developing a financial management platform for healthcare providers, raised $3.75 million in funding led by Redesign Health, with participation from Locke Health and KCRise Fund. Treso is building an intelligent operating system for care providers that combines accounting, receivables, expense management, procurement and business intelligence with banking and financial products. The Kansas City-based company aims to help independent physician practices manage the money coming into and going out of their businesses. Ryan Greenhaw, cofounder and CEO of Treso, told MobiHealthNews that the concept began as an expense management tool before being expanded to include...

Techstars
Sep 28th, 2026
Celebrating Demo Day: Northwestern Medicine & Techstars Healthcare Accelerator

Meet the five companies from the Northwestern Medicine & Techstars Healthcare Accelerator's latest class.

PR Newswire
Aug 25th, 2026
OmicsBank Raises $2.25M to Expand Clinical Data Infrastructure Globally for Healthcare, Life Sciences, and Frontier AI Labs

/PRNewswire/ -- OmicsBank, a clinical data infrastructure company connecting fragmented hospital data for drug development and healthcare AI, today announced...

Endpoints News
Aug 25th, 2026
Exclusive: OmicsBank raises $2.25M to bring overseas patient data to biopharma.

Exclusive: OmicsBank raises $2.25M to bring overseas patient data to biopharma. Health tech reporter. As AI aims to accelerate drug discovery, a growing number of health tech companies are betting that the ability to provide health... Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. Think Endpoints Company is worth reading - tell Google. Confirm Endpoints as a trusted biopharma news source